Adenosine inhibits ischemia-reperfusion injury (IRI), i.e. tissue damage that occurs during reperfusion following ischemia in liver, heart and other tissues. Preliminary data indicate that bone marrow-derived CD4+ T cells appear to be the most important targets of adenosine-mediated protection from IRI. The overall goal of this proposal is to better understand how adenosine markedly protects liver and heart from IRI. We hypothesize that endogenous glycolipid mediators and other factors produced during acute ischemia- reperfusion injury are presented to certain T lymphocytes by antigen presenting cells (APCs) resulting in their rapid activation. This activation is inhibited by adenosine produced in inflamed tissues. Possible targets of A2A agonists are CD4+ T effector cells (CD25-) NKT cells, antigen presenting cells (including macrophages and dendritic cells) and T regulatory cells (CD25+).
Aim 1 is to create tissue specific deletions n granulocytes, T cells, cardiomyocytes, endothelial cells and hepatocytes of the A2AAR gene through the use of the Cre/lox system. In addition, we will label various T cell populations in vitro with 111-ln and follow their trafficking non-invasively with ?-camera imaging following their transfer into wild-type mice. Hypothesis 1_is that cre/lox deletion of the A2AAR from T lymphocytes will greatly reduce adenosine-mediated tissue protection and enhance the trafficking of effector T cells into injured tissues. We hypothesize that T cell activation during reperfusion injury may initiate an inflammatory cascade in which macrophages and neutrophils are also activated.
Aim 2 is to investigate the role of macrophages in adenosine-mediated tissue protection. The activation of T cells during IRI appears to require the participation of antigen presenting cells (APCs) such as macrophages or dendritic cells. We will deplete macrophages from various mouse lines, using liposomal clodronate, and then to reconstitute mice with monocytic RAW cells that express various numbers of A2AARs. Hypothesis 2 is that the contribution of macrophages to tissue protection will be largely dependent on their expression of A2AARs and that the sensitivity of mice to protection by A2A agonists will be enhanced by prior inflammatory stimuli.
Aim 3 is to investigate the role of the A2AAR in vitro on T celll activation/proliferation in co-cultures of activated T effector cells or NKT cells, Treg cells and antigen- presenting splenocytes or dendritic cells, each derived from wild-type and/or A2AAR ko mice. Hypothesis 3 is that A2A receptors on all of these cells contribute to the regulation of T cell activation and proliferation These experiments will result in increased understanding about the role of the innate immune system in IRI and will provide new insights into the treatment of ischemic diseases and tissue transplantation. ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL037942-20
Application #
7171575
Study Section
Myocardial Ischemia and Metabolism Study Section (MIM)
Program Officer
Goldman, Stephen
Project Start
1986-07-01
Project End
2009-11-30
Budget Start
2006-12-01
Budget End
2007-11-30
Support Year
20
Fiscal Year
2007
Total Cost
$365,741
Indirect Cost
Name
University of Virginia
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
065391526
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Acuff, Nicole V; Linden, Joel (2017) Using Visualization of t-Distributed Stochastic Neighbor Embedding To Identify Immune Cell Subsets in Mouse Tumors. J Immunol 198:4539-4546
Cekic, Caglar; Sag, Duygu; Li, Yuesheng et al. (2012) Adenosine A2B receptor blockade slows growth of bladder and breast tumors. J Immunol 188:198-205
Awad, Alaa S; Rouse, Michael D; Khutsishvili, Konstantine et al. (2011) Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes. Kidney Int 79:1090-8
Figler, Robert A; Wang, Guoquan; Srinivasan, Susseela et al. (2011) Links between insulin resistance, adenosine A2B receptors, and inflammatory markers in mice and humans. Diabetes 60:669-79
Chhabra, Preeti; Wang, Kunjie; Zeng, Qiang et al. (2010) Adenosine A(2A) agonist administration improves islet transplant outcome: Evidence for the role of innate immunity in islet graft rejection. Cell Transplant 19:597-612
Schwindinger, William F; Mihalcik, Lauren J Murphree; Giger, Kathryn E et al. (2010) Adenosine A2A receptor signaling and golf assembly show a specific requirement for the gamma7 subtype in the striatum. J Biol Chem 285:29787-96
Alam, Mohammad S; Kurtz, Courtney C; Rowlett, Robert M et al. (2009) CD73 is expressed by human regulatory T helper cells and suppresses proinflammatory cytokine production and Helicobacter felis-induced gastritis in mice. J Infect Dis 199:494-504
Jo, Sang-Kyung; Bajwa, Amandeep; Ye, Hong et al. (2009) Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injury. Kidney Int 75:167-75
Awad, Alaa S; Rouse, Michael; Huang, Liping et al. (2009) Compartmentalization of neutrophils in the kidney and lung following acute ischemic kidney injury. Kidney Int 75:689-98
Wilson, Jeffrey M; Ross, William G; Agbai, Oma N et al. (2009) The A2B adenosine receptor impairs the maturation and immunogenicity of dendritic cells. J Immunol 182:4616-23

Showing the most recent 10 out of 58 publications